Scientific journal retracts three papers on MDMA-assisted therapy, NYT reports

Three papers on MDMA-assisted therapy have been retracted from the journal Psychopharmacology with the publication citing ‘unethical conduct’ at one of the study locations where research took place, the New York Times’ Andrew Jacobs reports, citing the retractions. Several of the papers’ authors are tied to Lykos Therapeutics, whose application for MDMA-assisted therapy to treat post-traumatic stress disorder was rejected last week by the FDA. Lykos said the research in the retracted papers was not part of the FDA application. Other companies working on psychedelic drugs include Mind Medicine (MNMD), Cybin (CYBN), Compass Pathways (CMPS) and Atai Life Sciences (ATAI).